The Legal Tensions of Collaboration and Competition in the Life Sciences Industry
Moderna’s suit against Pfizer and partner BioNtech over alleged COVID-vaccine-related patent infringement – and the targets’ countersuit – might suggest an abrupt return to business as usual after an unprecedented period of cooperation among life sciences companies during the height …